The bottom line is MK has failed too deliver what was promised and has cost investors loads of cash.The question is can he pull back what he has lost ?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025